Finance

Par Pharmaceutical reports first-quarter revenues of 78% to $173.8 million

Published in Law and Health Weekly, June 3rd, 2006

Par Pharmaceutical Companies, Inc. (PRX) reported that total revenues grew 78% to $173.8 million for the first quarter ended April 2, 2006.

For the quarter, income from continuing operations rose 212% to $8.4 million and diluted earnings per share from continuing operations increased 200% to $.24. This is compared with revenues of $97.5 million, income from continuing operations of $2.7 million and diluted earnings per share from continuing operations of $.08 for the same period a year ago. Effective December 31, 2005, Par divested FineTech Laboratories Ltd. Income from continuing operations for the first quarter of 2005 excludes the financial results of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2006-06-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry